← Open Payments lookup

BASHIR AHMED: Open Payments

NPI 1659537827 · FAIRVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$653 in 48 payments from 11 companies in 2025. Trend: 2023 $915 · 2024 $1,013 · 2025 $653

Food & beverage: $653
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$166
ABBVIE INC.14$163
Otsuka America Pharmaceutical, Inc.13$138
Alkermes, Inc.3$49
Janssen Pharmaceuticals, Inc1$25
Bausch Health US, LLC1$21
Noven Therapeutics, LLC1$20
E.R. Squibb & Sons, L.L.C.1$19
Tris Pharma Inc1$18
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: CAPLYTA, VRAYLAR, REXULTI, LYBALVI, INVEGA SUSTENNA, APLENZIN, Xelstrym, COBENFY.

Industry payments across TX — which companies pay providers there.